Characteristic | N = 1,0001 |
---|---|
Sex assigned at birth | |
Female | 1,000 (100%) |
Age (years) at first pregnancy | |
11-14 | 3 (0.3%) |
15-19 | 54 (5.4%) |
20-24 | 122 (12%) |
25-29 | 296 (30%) |
30-34 | 381 (38%) |
35-39 | 132 (13%) |
≥40 | 12 (1.2%) |
Race | |
American Indian or Alaska Native | 8 (0.8%) |
Asian | 70 (7.0%) |
Black or African American | 58 (5.8%) |
Native Hawaiian or Other Pacific Islander | 7 (0.7%) |
White | 838 (84%) |
Other | 19 (1.9%) |
Ehtnicity | |
Not Hispanic or Latino | 916 (92%) |
Hispanic or Latino | 82 (8.2%) |
Unknown | 2 (0.2%) |
BMI during imaging | 25.7 (22.8, 29.5) |
1 n (%); Median (IQR) |
Diagnostic Performance and Outcomes of Breast Imaging during Pregnancy and Lactation in an Academic Clinical Practice
Statistical analysis
Patient demographics
Patient demographics are summarized in Table 1.
BI-RADS 3 in pregnant vs. lactating by modality
The frequency and rate of BI-RADS 3 in pregnant and lactating women are summarized in Table 2 by imaging modality.
Modality | Pregnant | Lactating |
---|---|---|
Mammo-Screening | 0/0 | 0/89 (0%) |
Mammo-Diagnostic | 0/16 (0%) | 40/397 (10.1%) |
Ultrasound-Screening | 0/2 (0%) | 0/2 (0%) |
Ultrasound-Diagnostic | 34/244 (13.9%) | 88/605 (14.5%) |
MRI-Screening | 0/0 | 1/50 (2%) |
Pathology vs final diagnosis
Cross-tabulation of biopsy (Yes vs No) against final diagnosis status is shown in Table 3.
Final Diagnosis | Total | p-value1 | |||
---|---|---|---|---|---|
Benign | Malignant | Unknown | |||
Biopsy | <0.001 | ||||
No | 792 (90%) | 0 (0%) | 84 (9.6%) | 876 (100%) | |
Yes | 110 (89%) | 14 (11%) | 0 (0%) | 124 (100%) | |
Total | 902 (90%) | 14 (1.4%) | 84 (8.4%) | 1,000 (100%) | |
1 Fisher’s exact test |
In biopsied patients, 110 (89%) have benign diagnosis, comparable to 902 (90%) overall.
Malignancy rate after BI-RADS 3
Across all modalities, 123 patients got BI-RADS 3. Among them, none (0%) had a final malignant diagnosis.
Mammogaphy with tomosynthesis (DBT) and digital mammography (DM)
Table 4 below shows that the diagnostic performance (specificity) of DBT vs DM is similar.
Table 4: Diagnostic performance (specificity) of DBT vs DM.
Type | Result | n |
---|---|---|
DBT | False positive | 26 |
DBT | True negative | 157 |
DBT | True positive | 4 |
DM | False positive | 26 |
DM | True negative | 151 |
DM | True positive | 9 |
DBT | DM | P |
---|---|---|
0.858 (0.797, 0.903) | 0.853 (0.79, 0.9) | 1 |